Federal Register notice: FDA announces the renewal of its Medical Imaging Drugs Advisory Committee for an additional two years beyond the charter expi...
FDA Review posts the Federal Register notices for the week ending 5/3/2019.
FDA Review post product approval summaries for the week ending 5/3/2019.
Federal Register notice: FDA announces the approval of product that redeemed a priority review voucher Alexion Pharmaceuticals Ultomiris (ravulizumab...
Federal Register notice: FDA has made available its annual compilation of updates to the Susceptibility Test Interpretive Criteria Web page.
Federal Register notice: FDA makes available a list of patient preference-sensitive priorities on FDAs Web site entitled Patient Preference-Sensitive ...
FDA posts a draft guidance entitled Attention Deficit Hyperactivity Disorder (ADHD): Developing Stimulant Drugs for Treatment.
FDA clears a Treace Medical Concepts 510(k) to expand indications of the Lapiplasty 3D Bunion Correction System to treat pediatric patients 12 years o...